Dashboard
Manage Tickers

SGMO SANGAMO THERAPEUTICS, INC

Nasdaq sangamo.com


$ 0.59 $ 0.03 (4.55 %)    

Friday, 31-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.18 $ 3.02 (0.48 %)
DIA $ 475.66 $ 0.66 (0.14 %)
SPY $ 682.17 $ 2.23 (0.33 %)
TLT $ 90.32 $ -0.27 (-0.3 %)
GLD $ 368.12 $ -2.01 (-0.54 %)
$ 0.598
$ 0.58
$ 0.60 x 1,000
$ 0.63 x 50
$ 0.57 - $ 0.62
$ 0.41 - $ 3.18
4,469,193
na
172.58M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-13-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-08-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 02-28-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-18-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

on-september-9-sangamo-therapeutics-cfo-prathyusha-duraibabu-resigned
On September 9, Sangamo Therapeutics CFO P...
09/11/2025 21:08:32

-SEC Filing

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
09/04/2025 16:12:59

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $...

sangamo-therapeutics-q2-eps-008-misses-005-estimate-sales-18306m-miss-31680m-estimate
Sangamo Therapeutics Q2 EPS $(0.08) Misses...
08/07/2025 20:08:37

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
'South Africa, Gates Foundation Pledge Fun...
08/04/2025 16:40:22

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
06/24/2025 16:40:14

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

sangamo-therapeutics-announces-topline-results-from-registrational-phase-12-staar-of-st-920-in-fabry-disease-intends-to-submit-biologics-license-application-in-2026
Sangamo Therapeutics Announces Topline Res...
06/24/2025 12:10:25

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dose...

barclays-maintains-overweight-on-sangamo-therapeutics-lowers-price-target-to-5
Barclays Maintains Overweight on Sangamo T...
05/14/2025 15:07:44

Barclays analyst Gena Wang maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Overweight and lowers the price target from $...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 17:06:46

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

us-stocks-likely-to-open-lower-after-a-strong-rally-lows-are-likely-in-and-better-times-are-coming-says-expert
US Stocks Likely To Open Lower After A Str...
05/13/2025 09:45:38

U.S. stock futures fell on Tuesday after a stellar rally on Monday. Futures of major benchmark indices were trading lower in pr...

why-coinbase-global-shares-are-trading-higher-by-over-9-here-are-20-stocks-moving-premarket
Why Coinbase Global Shares Are Trading Hig...
05/13/2025 09:28:26

sangamo-therapeutics-q1-eps-014-misses-013-estimate-sales-644m-miss-742m-estimate
Sangamo Therapeutics Q1 EPS $(0.14) Misses...
05/12/2025 22:38:35

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

sangamo-therapeutics-prices-23m-underwritten-offering-of-12235m-shares-of-common-stock-and-pre-funded-warrants-at-050-and-049-respectively-including-accompanying-warrants-exercisable-at-075
Sangamo Therapeutics Prices $23M Underwrit...
05/12/2025 22:25:23

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced the pricing of an underwritten offering c...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
05/12/2025 21:06:02

sangamo-therapeutics-q1-gaap-eps-014-misses-013-estimate-sales-644m-miss-742m-estimate
Sangamo Therapeutics Q1 GAAP EPS $(0.14) M...
05/12/2025 20:37:08

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

sangamo-therapeutics-announces-derisking-milestones-for-pathway-to-anticipated-bla-submission-for-st-920-in-fabry-disease
Sangamo Therapeutics Announces Derisking M...
05/06/2025 12:36:00

All dosed patients have passed one-year milestone required by U.S. Food and Drug Administration (FDA) for Accelerated Approval ...

sangamo-therapeutics-to-present-at-28th-annual-meeting-of-the-american-society-of-gene--cell-therapy-may-13-17
Sangamo Therapeutics To Present At 28th An...
04/28/2025 20:33:14

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
04/07/2025 12:48:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $10 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION